OSX — Osteopore Cashflow Statement
0.000.00%
Last trade - 00:00- AU$1.91m
- AU$2.84m
- AU$3.06m
Annual cashflow statement for Osteopore, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.62 | -4.2 | -4.83 | -3.33 | -3.72 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.117 | 0.004 | 0.546 | 0.601 | 0.701 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.528 | -0.02 | 0.096 | -0.887 | -0.052 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -3.81 | -3.99 | -3.72 | -3.09 | -2.54 |
| Capital Expenditures | -0.195 | -0.064 | -0.007 | -0.015 | -0.011 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.195 | -0.064 | -0.007 | -0.015 | -0.011 |
| Financing Cash Flow Items | 0 | — | -0.015 | -0.326 | -0.016 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.486 | 0.896 | 3.56 | 2.63 | 2.65 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.5 | -3.2 | -0.219 | -0.476 | -0.012 |